News & Events
For media inquiries email [email protected]
Company news
October 28, 2024
Press Release
Parabilis Medicines™ – Formerly FogPharma – Announces New Company Name and Unveils AI- and Physics-Based Discovery Platform
Publications and presentations
March 5, 2024
Nature Communications
Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins
November 20, 2023
Nature Communications
Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptides
December 19, 2022
PNAS
De novo mapping of α-helix recognition sites on protein surfaces using unbiased libraries
Recent highlights
March 21, 2024
New York City
STAT Breakthrough Summit East
At the 2024 STAT Breakthrough Summit East, Parabilis Medicines CEO Mathai Mammen spoke on a panel entitled “The Future of Pharma R&D” alongside other industry leaders.